Cannabis RegulationGovernment & regulators

Department of Thai Traditional and Alternative Medicine

The Department of Thai Traditional and Alternative Medicine is a Thai government body under the public-health system. In cannabis-sector coverage, it is relevant because Thailand’s post-decriminalisation framework linked cannabis to medical, traditional-medicine, cultivation, dispensing, and compliance channels. The department’s role includes administrative oversight related to traditional-medicine use and licensed activity rather than commercial retail competition. It matters to operators because reporting, product controls, cultivation standards, and medical-use framing affect how cannabis businesses can remain compliant.

Profile overview

The Department of Thai Traditional and Alternative Medicine is a Thai government body under the public-health system. In cannabis-sector coverage, it is relevant because Thailand’s post-decriminalisation framework linked cannabis to medical, traditional-medicine, cultivation, dispensing, and compliance channels. The department’s role includes administrative oversight related to traditional-medicine use and licensed activity rather than commercial retail competition. It matters to operators because reporting, product controls, cultivation standards, and medical-use framing affect how cannabis businesses can remain compliant.

Public-record references
Data as of: 2024-2026

Regulatory programs

Medical cannabis oversight

Post-decriminalisation licensing and GACP compliance

DTTAM administers Good Agricultural and Collection Practices (GACP) compliance for cannabis cultivators, oversees monthly transaction-record submissions from licensed dispensaries, and enforces the medical-tier access framework established by the June 2025 Royal Gazette reclassification of cannabis flower as a controlled herb.

Traditional medicine licensing

Thai traditional medicine practitioner registration

DTTAM registers and licenses Thai traditional medicine practitioners (mor phaen thai) and traditional pharmaceutical manufacturers. Following the cannabis rollback, licensed traditional-medicine practitioners join Western-trained doctors and dentists as the three approved channels for cannabis prescription, creating a significant new access gate.

Dispensary renewal

Post-reform dispensary compliance enforcement

Of 18,433 dispensaries operating under the pre-rollback framework, 7,297 reportedly closed and only 1,339 renewed licences under stricter post-2025 rules. DTTAM's dispensary inspection and record-keeping enforcement capacity is the operational constraint determining how many compliant medical-tier operators can remain viable.

Product standards

Cannabis-derived product registration and controls

Cannabis-derived pharmaceutical products — CBD oils, topical preparations, and approved cannabis-extract medicines — require DTTAM product-registration approval under the Traditional Medicine Act. Online sales, vending-machine sales, and proximity-restriction violations (near schools, temples) are subject to DTTAM enforcement actions.

Thai cannabis regulatory actors — sector overview

DTTAM

Role

Cannabis licensing, GACP, dispensary oversight, traditional-medicine practitioner access

Statutory authority

Thai Traditional Medicine Act, Public Health Ministry

Thai FDA (ACFS)

Role

Cannabis-derived pharmaceutical product registration

Statutory authority

Drug Act, Ministry of Public Health

Ministry of Public Health

Role

Policy framework, ministerial orders (Cannabis and Hemp Act stalled)

Statutory authority

Ministerial orders 2025

Office of Narcotics Control Board

Role

Enforcement of controlled-herb classification

Statutory authority

Narcotics Act amendment

Local authorities

Role

Proximity-restriction enforcement (schools, temples)

Statutory authority

Municipal by-laws

Watchpoints 2025–2026

Enforcement capacity

DTTAM inspection resources versus licensed-operator count

DTTAM's inspection capacity — staff, provincial office coverage, and digital record-keeping systems — determines how effectively the post-rollback compliance regime operates. Under-resourcing creates leakage risk: unlicensed operators continue serving recreational demand while compliant medical operators face disproportionate audit burden.

Cannabis and Hemp Act

Stalled legislation creating operating uncertainty

Thailand's Cannabis and Hemp Act — which would provide permanent statutory framework for the medical-cannabis tier — remains stalled in parliament as of May 2026. Ministerial orders serve as the operative framework, creating legal uncertainty for capital investment decisions by compliant medical operators and pharmaceutical manufacturers.

Export potential

Medical-grade cannabis export licensing framework

Thailand's GACP-certified cultivation infrastructure positions it as a potential medical-cannabis exporter to EU markets (GMP-certified). DTTAM must develop an export-licensing framework distinct from domestic dispensary rules. If export licensing progresses, it creates a premium revenue pathway for licensed cultivators beyond domestic medical supply.

Source-pack context

Department of Thai Traditional and Alternative Medicine is linked to existing Insight report coverage through tracked source packs. The cited sources provide the current evidence trail for market context, regulatory exposure, operator positioning, or sector structure; exact numeric claims should still be checked against raw snapshots before being surfaced as headline metrics.[, , ]

Deep operating read

The Department of Thai Traditional and Alternative Medicine is now the operational gatekeeper for Thailand's post-decriminalisation cannabis rollback. The report states that the Royal Gazette reclassified cannabis flower as a controlled herb on 26 June 2025, moving access to medical-only prescriptions by doctors, traditional Thai medicine practitioners, and dentists. DTTAM's practical role is licensing, GACP compliance, monthly transaction records, and enforcement of the medical-tier regime.[, , , ]

Execution watchpoints

The main watchpoint is enforcement capacity after a sudden market contraction: 7,297 of 18,433 dispensaries reportedly shut after license-renewal failures, and only 1,339 renewed under stricter rules. Online sales, vending machines, and sales near schools, temples, or sensitive areas are banned, so leakage will test DTTAM's inspection and recordkeeping systems. The stalled Cannabis and Hemp Act means ministerial orders remain the operating framework, creating legal uncertainty for compliant medical operators.[, , , ]

Related Market profiles

Peers, parents, partners, agencies, and other Cannabis Regulation actors.

Reports featuring this profile

Related Market profiles

Department of Thai Traditional and Alternative Medicine - Market Atlas · Insight